IHL 0.00% 4.1¢ incannex healthcare limited

General discussion, page-15044

  1. 1,235 Posts.
    lightbulb Created with Sketch. 1543
    APIRx... sell retail?
    I don't think you have a clue.

    APIRx is biotech: their main assets are drug candidates and process IP: that didn't change when Incannex acquired them.
    At the current hour, Incannex remains a pure play biotech. They didn't buy APIRx for the couple of gum products the company had brought to market, but for the 22 clinical and pre-clinical programs the company possesses. You would know this from even a cursory read of any of several company releases on the APIRx acquisition.
 
watchlist Created with Sketch. Add IHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.